ResMed Inc. (RMD)
NYSE: RMD · IEX Real-Time Price · USD
189.35
+2.41 (1.29%)
At close: Jul 2, 2024, 4:00 PM
190.73
+1.38 (0.73%)
After-hours: Jul 2, 2024, 7:46 PM EDT
ResMed Revenue
ResMed had revenue of $4.58B in the twelve months ending March 31, 2024, with 14.16% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.20B with 7.17% year-over-year growth. In the fiscal year ending June 30, 2023, ResMed had annual revenue of $4.22B with 18.02% growth.
Revenue (ttm)
$4.58B
Revenue Growth
+14.16%
P/S Ratio
6.07
Revenue / Employee
$452,087
Employees
10,140
Market Cap
27.82B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
Jun 30, 2019 | 2.61B | 266.38M | 11.38% |
Jun 30, 2018 | 2.34B | 273.46M | 13.23% |
Jun 30, 2017 | 2.07B | 228.02M | 12.40% |
Jun 30, 2016 | 1.84B | 159.80M | 9.52% |
Jun 30, 2015 | 1.68B | 123.94M | 7.97% |
Jun 30, 2014 | 1.55B | 40.52M | 2.68% |
Jun 30, 2013 | 1.51B | 145.94M | 10.66% |
Jun 30, 2012 | 1.37B | 125.37M | 10.08% |
Jun 30, 2011 | 1.24B | 150.79M | 13.80% |
Jun 30, 2010 | 1.09B | 171.62M | 18.64% |
Jun 30, 2009 | 920.74M | 85.34M | 10.22% |
Jun 30, 2008 | 835.40M | 119.07M | 16.62% |
Jun 30, 2007 | 716.33M | 109.34M | 18.01% |
Jun 30, 2006 | 607.00M | 181.49M | 42.65% |
Jun 30, 2005 | 425.51M | 86.17M | 25.39% |
Jun 30, 2004 | 339.34M | 65.77M | 24.04% |
Jun 30, 2003 | 273.57M | 69.49M | 34.05% |
Jun 30, 2002 | 204.08M | 48.92M | 31.53% |
Jun 30, 2001 | 155.16M | 39.54M | 34.20% |
Jun 30, 2000 | 115.62M | 26.99M | 30.45% |
Jun 30, 1999 | 88.63M | 22.11M | 33.24% |
Jun 30, 1998 | 66.52M | 17.34M | 35.26% |
Jun 30, 1997 | 49.18M | 14.62M | 42.30% |
Jun 30, 1996 | 34.56M | 11.06M | 47.07% |
Jun 30, 1995 | 23.50M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 220.57B |
Centene | 155.52B |
Koninklijke Philips | 20.19B |
Biogen | 9.66B |
ICON PLC | 8.23B |
Mettler-Toledo International | 3.79B |
West Pharmaceutical Services | 2.93B |
Veeva Systems | 2.49B |
RMD News
- 5 days ago - ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. - Barrons
- 8 days ago - ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday - Benzinga
- 8 days ago - Why a Pair of Eli Lilly Clinical Trials Sent ResMed Stock Tumbling - Investopedia
- 8 days ago - Medical-device makers ResMed and Inspire slump after Lilly's Zepbound trial shows benefits for sleep apnea - Market Watch
- 8 days ago - ResMed Stock Is Sinking. Blame Lilly's Zepbound Trials for Sleep Apnea. - Barrons
- 22 days ago - PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia - GlobeNewsWire
- 5 weeks ago - Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy - GlobeNewsWire
- 6 weeks ago - ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy - GlobeNewsWire